Biomarkers and Drug Discovery: Jeffrey L. Goldberg, MD, PhD

Jeffrey L. Goldberg, MD, PhD (Professor and Chair, Department of Ophthalmology, Stanford University School of Medicine) presented research advances from the Catalyst for a Cure (CFC) biomarkers team at the Glaucoma 360 New Horizons Forum in San Francisco on February 3, 2017. The title of Dr. Goldberg’s talk was “Biomarkers and Drug Discovery: Integrating therapeutic and diagnostic models.”